Arcus Biosciences (RCUS)
(Delayed Data from NYSE)
$15.43 USD
-0.07 (-0.45%)
Updated Apr 24, 2024 04:00 PM ET
After-Market: $15.44 +0.01 (0.06%) 7:58 PM ET
4-Sell of 5 4
F Value F Growth A Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/14/2024
Time: -- |
3/2024 | $-0.97 | -25.39% |
Earnings Summary
For their last quarter, Arcus Biosciences (RCUS) reported earnings of -$1.08 per share, beating the Zacks Consensus Estimate of $-1.09 per share. This reflects a positive earnings surprise of 0.92%. Look out for RCUS's next earnings release expected on May 14, 2024. For the next earning release, we expect the company to report earnings of -$0.97 per share, reflecting a year-over-year increase of 11.01%.
Earnings History
Price & Consensus
Zacks News for RCUS
C4 Therapeutics (CCCC) to Report Q4 Earnings: What's in Store?
RCUS: What are Zacks experts saying now?
Zacks Private Portfolio Services